Strong performer for RPA, Cyclone Robotics, is the Customer Choice for APAC region

SINGAPORE, Jan. 5, 2023 /PRNewswire/ — Leading provider of robotic software and solutions, Cyclone Robotics has…

Sphera Marks a Decade as a Market Leader in EHS Software in Independent Analyst Report

The 2023 Green Quadrant EHS Software report sees Sphera receiving top scores for ESG and sustainability…

Duality Biologics Announces License Agreement of its Next-generation ADC platform with Adcendo

Duality to grant license of DITAC (Duality Immune Toxin Antibody Conjugates) platform to Adcendo for its…

CardsPal named the official Ticketing Partner for Seedly Personal Finance Festival 2023, Singapore’s biggest personal finance festival

SINGAPORE, Jan. 5, 2023 /PRNewswire/ — CardsPal has secured another win by being appointed as the…

WuXi Biologics and GSK Enter into License Agreement on Multiple Novel Bi- & Multi-specific T Cell Engagers

WuXi Biologics will provide an exclusive license to GSK for one preclinical bi-specific T cell engaging…

INUITIVE AND VISIDON INTRODUCE A NEW, INDUSTRY-CHANGING LOW LIGHT ENHANCEMENT TECHNOLOGY FOR ROBOTIC APPLICATIONS AND MORE

The solution’s fast, neural networks-based low light enhancement capability functions in real time, enabling precision in…

Innovent Announces NMPA’s Breakthrough Therapy Designation for IBI351 (KRAS G12C Inhibitor) as Monotherapy for Previous Treated Advanced Non-small Cell Lung Cancer

ROCKVILLE, Md. and SUZHOU, China, Jan. 5, 2023 /PRNewswire/ — Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a…

A Cross-Generational Upgrade for Hisense, ULED X Technology Debuts at CES 2023

LAS VEGAS, Jan. 5, 2023 /PRNewswire/ — On January 4th, Hisense unveiled ULED X at Hisense…

Hisense CES 2023: Expanding Global Footprint and Paving the Way for Ongoing Growth

LAS VEGAS, Jan. 5, 2023 /PRNewswire/ — On January 4th, David Gold, President of Hisense USA, delivered…

Cognos Therapeutics, Inc. to Become Publicly Listed on Nasdaq via Business Combination with Nocturne Acquisition Corporation

Cognos Therapeutics is a medical technology company focused on developing unique, radically advanced devices for the…